Healthy Clinical Trial
Official title:
The Effects of Shoes With Different Heel Heights on Balance, Muscular Endurance and Functional Skills
Verified date | January 2020 |
Source | Eastern Mediterranean University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In daily life, stiletto heeled shoes which are popularly preferred by women have different heel heights. This study aims to investigate the effects of these differences on balance, muscular endurance and functional skills. Heel heights were chosen as 4 and 10 cm. Other features of shoes (stiletto type/colour etc.) will be same. The tests will be randomly done barefoot, 10 cm, and 4cm shoes.
Status | Completed |
Enrollment | 40 |
Est. completion date | March 10, 2019 |
Est. primary completion date | February 15, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria: - the shoe number will be 37 - women who do not regularly wear high heeled shoes - women who are familiar with stiletto heeled shoes Exclusion Criteria: - any pain which prevents to participate in tests - women with cardiovascular disease, metabolic disease, blood pressure disorders, diabetes diseases, neuromuscular diseases. |
Country | Name | City | State |
---|---|---|---|
Cyprus | Zehra Güçhan Topcu | Famagusta |
Lead Sponsor | Collaborator |
---|---|
Eastern Mediterranean University |
Cyprus,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Repetition number of heel raising | Before the test, the case will be asked to stretch plantar flexor muscles. Then the case will be asked to raise the heels unilaterally. The repetition number will be written until the case cannot do the full movement. | at baseline | |
Other | Repetition number of squating | Before the test, the case will be asked to stretch quadriceps muscle with flexing the knee. Then the case will be asked to squat continuously. The repetition number will be written until the case cannot do the full movement. | at baseline | |
Other | Duration of heel raising | Before the test, the case will be asked to stretch plantar flexor muscles. Then the case will be asked to raise the heels unilaterally. The time (in seconds) will be written until the case cannot do the full movement. | at baseline | |
Other | Duration of squating | Before the test, the case will be asked to stretch quadriceps muscle with flexing the knee. Then the case will be asked to squat continuously. The time (in seconds) will be written until the case cannot do the full movement. | Before the test, the case will be asked to stretch quadriceps muscle with flexing the knee. Then the case will be asked to squat continuously. The repetition number will be written until the case cannot do the full movement. | |
Other | Functional Forward Reach Test | Before the test, the case will be asked to stretch quadriceps muscle with flexing the knee. Then the case will be asked to squat continuously. The repetition number will be written until the case cannot do the full movement. | Before the test, the case will be asked to stretch quadriceps muscle with flexing the knee. Then the case will be asked to squat continuously. The repetition number will be written until the case cannot do the full movement. | |
Primary | Functional Skill | The case will be asked to climb up 10 stairs as fast as possible. Time (in seconds) will be recorded for climbing up with and without heel contact. | at baseline | |
Secondary | Single Leg Standing | The case will be asked to stand on dominant leg. If the raised leg touches anything around (other limb, floor) or in condition of hopping/splashing, time will be stopped. Time (seconds) will be recorded. | at baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |